Skip to main content
Fig. 4 | Genes and Environment

Fig. 4

From: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

Fig. 4

NCAPD2-related genes enrichment analysis. (A) A PPI network of 20 NCAPD2-interacted proteins. (B) The KEGG enrichment analysis of NCAPD2. (C) The BP enrichment analysis of NCAPD2. (D) The MF and CC enrichment analysis of NCAPD2. (E) Intersection analysis of NCAPD2 similar genes and NCAPD2-interacted proteins. (F) NCAPG, NCAPH and ASPM have strong positive correlations with NCAPD2 expression in different cancers. (G) Clinical expression levels of NCAPD2 and NCAPG, NCAPH, and ASPM in THYM

Back to article page